Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$30.46 - $46.04 $1.31 Million - $1.99 Million
43,160 Added 31.48%
180,260 $5.49 Million
Q2 2023

Aug 14, 2023

BUY
$31.57 - $37.73 $255,717 - $305,613
8,100 Added 6.28%
137,100 $5.12 Million
Q1 2023

May 15, 2023

BUY
$29.72 - $41.45 $1.04 Million - $1.45 Million
35,050 Added 37.31%
129,000 $4.12 Million
Q4 2022

Feb 14, 2023

BUY
$30.23 - $38.71 $604,600 - $774,200
20,000 Added 27.05%
93,950 $3.35 Million
Q3 2022

Nov 14, 2022

BUY
$22.51 - $38.27 $546,993 - $929,961
24,300 Added 48.94%
73,950 $2.15 Million
Q2 2022

Aug 15, 2022

SELL
$20.97 - $37.47 $56,619 - $101,169
-2,700 Reduced 5.16%
49,650 $1.11 Million
Q1 2022

May 16, 2022

SELL
$34.38 - $65.77 $929,979 - $1.78 Million
-27,050 Reduced 34.07%
52,350 $1.93 Million
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $2.51 Million - $3.85 Million
39,310 Added 98.05%
79,400 $5.6 Million
Q3 2021

Nov 15, 2021

SELL
$45.58 - $88.24 $1.39 Million - $2.7 Million
-30,570 Reduced 43.26%
40,090 $6.39 Million
Q2 2021

Aug 16, 2021

SELL
$34.4 - $48.34 $51,600 - $72,510
-1,500 Reduced 2.08%
70,660 $6.69 Million
Q1 2021

May 17, 2021

BUY
$23.17 - $38.3 $870,265 - $1.44 Million
37,560 Added 108.55%
72,160 $5.22 Million
Q4 2020

Feb 16, 2021

BUY
$18.28 - $23.85 $142,584 - $186,030
7,800 Added 29.1%
34,600 $1.64 Million
Q3 2020

Nov 16, 2020

BUY
$12.91 - $18.51 $59,386 - $85,146
4,600 Added 20.72%
26,800 $970,000
Q2 2020

Aug 14, 2020

SELL
$9.68 - $17.5 $372,389 - $673,225
-38,470 Reduced 63.41%
22,200 $629,000
Q1 2020

May 15, 2020

BUY
$7.43 - $24.88 $214,504 - $718,285
28,870 Added 90.79%
60,670 $1.3 Million
Q4 2019

Feb 14, 2020

BUY
$11.01 - $27.92 $350,118 - $887,856
31,800 New
31,800 $1.25 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.